Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.48 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.40 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.35 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3137231 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ALOX15HSD17B10LMNAPTPN1 | |
| SCHEMBL7848629 | 1.00 | ALDH1A1 (0.48) | ALDH1A1ALOX15HSD17B10LMNAPTPN1 | |
| SCHEMBL8022947 | 0.84 | ALDH1A1 (0.41) | ALDH1A1ALOX15HSD17B10LMNAPTPN1 | |
| SCHEMBL11600807 | 0.82 | ALDH1A1 (0.49) | ALDH1A1ALOX15HSD17B10LMNAPTPN1 | |
| SCHEMBL11785322 | 0.82 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL1070989 | 0.82 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL11600809 | 0.82 | ALDH1A1 (0.49) | ALDH1A1ALOX15HSD17B10LMNAPTPN1 | |
| SCHEMBL1070992 | 0.82 | ALDH1A1 (0.71) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL13288245 | 0.81 | ALDH1A1 (0.69) | ALDH1A1ALOX15PTPN1 | |
| SCHEMBL6765418 | 0.80 | NAAA (0.36) | ALDH1A1ALOX15HSD17B10LMNABTN3A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 409 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115974690-B | Preparation method of 4-acetoxyl-2-methyl-2-butene-1-aldehyde | 广州智特奇生物科技股份有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-119977806-A | Method for preparing 4-acetoxyl-2-methyl-2-butenal | 浙江芳原馨生物医药有限公司 | 2025-05-13 | — | — | CN | claimed |
| US-20250083137-A1 | SUPPORTED HYDROFORMYLATION CATALYST AND PREPARATION METHOD THEREOF, AND METHOD FOR SYNTHESIZING 4-ACETYLOXY-2-METHYL-2-BUTENAL | SHAOXING UNIVERSITY (CN) | 2025-03-13 | — | — | US | claimed |
| CN-116082206-B | Preparation method of vitamin A | 万华化学集团股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118684579-A | Method for preparing 2-methyl-4-acetoxyl-2-butenal by one-step method | 浙江芳原馨生物医药有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-114835577-B | Aldehyde synthesis method | 安徽智新生化有限公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2023108327-A1 | PREPARATION METHOD FOR LIGHT-COLORED VITAMIN A | 万华化学集团股份有限公司 | 2023-06-22 | — | — | WO | claimed |
| CN-113603592-B | Preparation method of 2-methyl-4-acetoxyl-2-butenal with thermal stability | 万华化学集团股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-116082206-A | Preparation method of vitamin A | 万华化学集团股份有限公司 | 2023-05-09 | — | — | CN | claimed |
| CN-115974690-A | Preparation method of 4-acetoxyl-2-methyl-2-butene-1-aldehyde | 广州智特奇生物科技股份有限公司 | 2023-04-18 | — | — | CN | claimed |
| CN-103553917-A | Method for preparing 3,7,11-trimethyl-2,4,6,10-dodecyl tetrenol acetic acid ester and application thereof | UNIV SHAOXING | 2014-02-05 | — | — | CN | claimed |
| CN-103553918-A | Preparation method and application of terpenoid 3,7,11-trimethyl-2,4,6,10-dodecatetraene-1-alcohol acetate | UNIV SHAOXING | 2014-02-05 | — | — | CN | claimed |
| CN-103553916-A | Preparation method and application of 3,7,11-trimethyl-2,4,6,10-dodecatetraene-1-alcohol acetate | UNIV SHAOXING | 2014-02-05 | — | — | CN | claimed |
| EP-2665698-A1 | PREPARATION OF 4-ACETOXY-2-METHYLBUTANAL BY CATALYTIC CARBON CARBON DOUBLE BOND HYDROGENATION | DSM IP Assets B.V. (NL) | 2013-11-27 | — | — | EP | claimed |
| WO-2012098067-A1 | PREPARATION OF 4-ACETOXY-2-METHYLBUTANAL BY CATALYTIC CARBON CARBON DOUBLE BOND HYDROGENATION | DSM IP ASSETS B.V. (NL) | 2012-07-26 | — | — | WO | claimed |
| EP-0579113-B1 | Improved process for preparing cyclic acetals of 3-formyl-2-butenyl-triphenylphosphonium chloride | BASF AG (DE) | 1997-05-02 | — | — | EP | claimed |
| US-5344995-A | Preparation of cyclic acetals of 3-formyl-2-butenyltriphenylphosphonium chloride | BASF AKTIENGESELLSCHAFT (DE) | 1994-09-06 | — | — | US | claimed |
| EP-0008581-A1 | METHOD OF PREPARING E-4-ACETOXY-2-METHYL-2-BUTENAL | BABLER, James, H. (US) | 1980-03-05 | — | — | EP | claimed |
| US-4175204-A | Method of preparing E-4-acetoxy-2-methyl-2-butenal | BABLER JAMES H | 1979-11-20 | — | — | US | claimed |
| WO-1979000485-A1 | METHOD OF PREPARING E-4-ACETOXY-2-METHYL-2-BUTENAL | BABLER J | 1979-07-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250083137-A1 | SUPPORTED HYDROFORMYLATION CATALYST AND PREPARATION METHOD THEREOF, AND METHOD FOR SYNTHESIZING 4-ACETYLOXY-2-METHYL-2-BUTENAL | NQO1, PNN, HPGD | ALDH1A1 72/4885ALOX15 128/4885HSD17B10 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.